betoptic betaxolol 5mg/ml (as hydrochloride) eye drops bottle
novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride, quantity: 5.6 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; sodium hydroxide; sodium chloride; hydrochloric acid; disodium edetate; purified water - indications as at 23 march 1999: betoptic 0.5% have been shown to be effective in lowering intraocular pressure and are indicated in the treatment of ocular hypertension or chronic open angular glaucoma. betoptic eye drops 0.5% may be used alone or in combination with other iop-lowering medication.
betoptic- betaxolol hydrochloride solution/ drops
alcon - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - solution/ drops - 5.6 mg in 1 ml - betoptic ophthalmic solution has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma. it may be used alone or in combination with other anti-glaucoma drugs. in clinical studies betoptic was safely used to lower intraocular pressure in 47 patients with both glaucoma and reactive airway disease who were followed for a mean period of 15 months. however, caution should be used in treating patients with severe reactive airway disease or a history of asthma. hypersensitivity to any component of this product. betoptic ophthalmic solution is contraindicated in patients with sinus bradycardia, greater than a first degree atrioventricular block, cardiogenic shock, or patients with overt cardiac failure.
betoquin betaxolol 5.0mg/ml (as hydrochloride) eye drops solution bottle
novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride, quantity: 5.6 mg/ml (equivalent: betaxolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: purified water; disodium edetate; sodium chloride; hydrochloric acid; benzalkonium chloride; sodium hydroxide - indications as at 23 march 1999: betoquin eye drops 0.5% have been shown to be effective in lowering intraocular pressure and are indicated in the treatment of ocular hypertension or chronic open angular glaucoma. betoquin eye drops 0.5% may be used alone or in combination with other iop-lowering medication.
betoptic
novartis new zealand ltd - betaxolol hydrochloride 0.56% equivalent to betaxolol 5 mg/ml; ; ; - eye drops, solution - 0.5 % - active: betaxolol hydrochloride 0.56% equivalent to betaxolol 5 mg/ml excipient: benzalkonium chloride as 50%soln + 5% overage. equiv. to 0.1mg/ml disodium edetate dihydrate hydrochloric acid purified water sodium chloride sodium hydroxide - the treatment of ocular hypertension or chronic open angle glaucoma. may be used alone or in combination with other iop-lowering medication.
betoptic s
novartis new zealand ltd - betaxolol hydrochloride 0.28%{relative} equivalent to to betaxolol 2.5 mg/ml - eye drops, suspension - 0.25% w/v - active: betaxolol hydrochloride 0.28%{relative} equivalent to to betaxolol 2.5 mg/ml excipient: amberlite benzalkonium chloride as 50% soln + 5% overage. equiv. to 0.1mg/ml carbomer disodium edetate dihydrate hydrochloric acid mannitol purified water sodium hydroxide - the treatment of ocular hypertension or chronic open angle glaucoma. may be used alone or in combination with other iop-lowering medication.
betoptic 0.25% eye drops suspension 0.25ml unit dose
immedica pharma ab - betaxolol hydrochloride - eye drops - 2.5mg/1ml
betoptic 0.5% w/v eye drops, solution
pco manufacturing ltd. - betaxolol hydrochloride - eye drops, solution - 0.5% percent weight/volume - beta blocking agents1); betaxolol
betoptic 0.5 base %w/v eye drops solution
ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v
betoptic 0.5 %w/v eye drops solution
alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - beta blocking agents
betoptic 0.5% w/v eye drops, solution
imbat limited - betaxolol hydrochloride - eye drops, solution - 0.5 base %w/v - beta blocking agents1); betaxolol